Release Date: 2024-05-31

Nutritional Supplements for Brain Health

Gozde Hasbal-Celikok (Author)

Release Date: 2024-05-31

Maintaining cognitive function throughout life is increasingly important as life expectancy rises. This chapter explores the role of nutritional supplements in promoting brain health. With a focus on deficiencies and limitations of dietary intake alone, the chapter examines the potential of specific supplements, including vitamins B9 and B12, omega-3 fatty acids, and Ginkgo biloba extract [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inBrain Health and Medicinal Plants
    First Page185
    Last Page216
    DOIhttps://doi.org/10.69860/nobel.9786053359241.10
    Page Count32
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    Maintaining cognitive function throughout life is increasingly important as life expectancy rises. This chapter explores the role of nutritional supplements in promoting brain health. With a focus on deficiencies and limitations of dietary intake alone, the chapter examines the potential of specific supplements, including vitamins B9 and B12, omega-3 fatty acids, and Ginkgo biloba extract (EGb 761), to enhance cognitive function and potentially prevent neurodegenerative diseases like dementia. By critically evaluating scientific evidence, the chapter aims to provide a balanced perspective on the potential benefits and limitations of nutritional supplements for cognitive health.

    Gozde Hasbal-Celikok (Author)
    Assistant Professor, İstinye University
    https://orcid.org/0000-0002-0216-7635
    3Gozde Hasbal-Celikok received her undergraduate degree in Biology from Istanbul University, Faculty of Science, followed by master’s degrees in Biochemistry at the university’s Faculty of Pharmacy, Department of Biochemistry. She completed her doctorate in 2019 at Istanbul University, Istanbul Faculty of Medicine, Department of Medical Biochemistry. Hasbal-Celikok currently serves as an Assistant Professor in the Department of Biochemistry at Istanbul University’s Faculty of Pharmacy, having joined the faculty in 2023. Hasbal-Celikok’s research interests lie at the intersection of natural product discovery, medicinal chemistry, and human health. She investigates natural products for potential therapeutic properties, aiming to develop novel agents through medicinal chemistry approaches. Specifically, her research focuses on overcoming drug resistance in cancer and exploring the health benefits associated with various plant sources.

    • Pomeroy, D. E., Tooley, K. L., Probert, B., Wilson, A., & Kemps, E. (2020). A systematic review of the effect of dietary supplements on cognitive performance in healthy young adults and military personnel. Nutrients, 12(2), 545.

    • Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., ... & Grimm, M. O. W. (2022). Mechanistic link between vitamin B12 and Alzheimer’s disease. Biomolecules, 12(1), 129.

    • Liang, L. (2020). Folates: Stability and interaction with biological molecules. Journal of Agriculture and Food Research, 2, 100039.

    • West, A. A., Caudill, M. A., & Bailey, L. B. (2020). Folate. In Present Knowledge in Nutrition (pp. 239-255). Academic Press.

    • Pravst, I., Lavriša, Ž., Hribar, M., Hristov, H., Kvarantan, N., Seljak, B. K., ... & Kušar, A. (2021). Dietary intake of folate and assessment of the folate deficiency prevalence in Slovenia using serum biomarkers. Nutrients, 13(11), 3860.

    • Sobczyńska-Malefora, A., & Smith, A. D. (2022). Vitamin B-12. Advances in Nutrition, 13(5), 2061-2063.

    • Batista, K. S., Cintra, V. M., Lucena, P. A., Manhães-de-Castro, R., Toscano, A. E., Costa, L. P., ... & Aquino, J. D. S. (2022). The role of vitamin B12 in viral infections: A comprehensive review of its relationship with the muscle–gut–brain axis and implications for SARS-CoV-2 infection. Nutrition reviews, 80(3), 561-578.

    • Rizzo, G., & Laganà, A. S. (2020). A review of vitamin B12. Molecular Nutrition, 105-129.

    • Singh, J. (2021). Vitamin B9 in dark green vegetables: Deficiency disorders, bio-availability, and fortification ıssues. In B-Complex Vitamins-Sources, Intakes and Novel Applications. IntechOpen.

    • Jedut, P., Szwajgier, D., Glibowski, P., & Iłowiecka, K. (2021). Some plant food products present on the polish market are a source of Vitamin B12. Applied Sciences, 11(8), 3601.

    • Caffrey, A., Lamers, Y., Murphy, M. M., Letourneau, N., Irwin, R. E., Pentieva, K., ... & McNulty, H. (2023). Epigenetic effects of folate and related B vitamins on brain health throughout life: Scientific substantiation and translation of the evidence for health improvement strategies. Nutrition Bulletin.

    • Temova Rakuša, Ž., Roškar, R., Hickey, N., & Geremia, S. (2022). Vitamin B12 in foods, food supplements, and medicines-A Review of its role and properties with a focus on its stability. Molecules, 28(1), 240.

    • Nawaz, A., Khattak, N. N., Khan, M. S., Nangyal, H., Sabri, S., & Shakir, M. (2020). Deficiency of vitamin B12 and its relation with neurological disorders: A critical review. The Journal of Basic and Applied Zoology, 81(1), 10.

    • Scarmeas, N., Anastasiou, C. A., & Yannakoulia, M. (2018). Nutrition and prevention of cognitive impairment. The Lancet Neurology, 17(11), 1006-1015.

    • Markun, S., Gravestock, I., Jäger, L., Rosemann, T., Pichierri, G., & Burgstaller, J. M. (2021). Effects of vitamin B12 supplementation on cognitive function, depressive symptoms, and fatigue: A systematic review, meta-analysis, and meta-regression. Nutrients, 13(3), 923.

    • Steegers-Theunissen, R. P. (1995). Folate metabolism and neural tube defects: A review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 61(1), 39-48.

    • Molloy, A. M., Kirke, P. N., Brody, L. C., Scott, J. M., & Mills, J. L. (2008). Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food and Nutrition Bulletin, 29(2), S101-S111.

    • Snowdon, D. A., Tully, C. L., Smith, C. D., Riley, K. P., & Markesbery, W. R. (2000). Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study. The American Journal of Clinical Nutrition, 71(4), 993-998.

    • Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007). Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. The Lancet, 369(9557), 208-216.

    • Strand, T. A., Taneja, S., Ueland, P. M., Refsum, H., Bahl, R., Schneede, J., ... & Bhandari, N. (2013). Cobalamin and folate status predicts mental development scores in North Indian children 12–18 mo of age. The American Journal of Clinical Nutrition, 97(2), 310-317.

    • Freitas-Costa, N. C., Andrade, P. G., Normando, P., Nunes, K. S. S., Raymundo, C. E., de Castro, I. R. R., ... & Kac, G. (2023). Association of development quotient with nutritional status of vitamins B6, B12, and folate in 6–59-month-old children: Results from the Brazilian National Survey on Child Nutrition (ENANI-2019). The American Journal of Clinical Nutrition, 118(1), 162-173.

    • Nguyen, C. T., Gracely, E. J., & Lee, B. K. (2013). Serum folate but not vitamin B-12 concentrations are positively associated with cognitive test scores in children aged 6–16 years. The Journal of Nutrition, 143(4), 500-504.

    • Compañ-Gabucio, L. M., Torres-Collado, L., Garcia-De la Hera, M., Fernández-Somoano, A., Tardón, A., Julvez, J., ... & Vioque, J. (2022). Association between the use of folic acid supplements during pregnancy and children’s cognitive function at 7–9 years of age in the INMA cohort study. International Journal of Environmental Research and Public Health, 19(19), 12123.

    • Groot, J., Petersen, T. G., Suren, P., Brantsæter, A. L., Uldall, P., Martinussen, T., ... & Strandberg-Larsen, K. (2022). Maternal intake of folate during pregnancy and risk of cerebral palsy in the MOBAND-CP cohort. The American Journal of Clinical Nutrition, 115(2), 397-406.

    • O’Connor, D. M., Scarlett, S., De Looze, C., O’Halloran, A. M., Laird, E., Molloy, A. M., ... & Kenny, R. A. (2022). Low folate predicts accelerated cognitive decline: 8-year follow-up of 3140 older adults in Ireland. European Journal of Clinical Nutrition, 76(7), 950-957.

    • Jiang, X., Guo, Y., Cui, L., Huang, L., Guo, Q., & Huang, G. (2023). Study of diet habits and cognitive function in the Chinese middle-aged and elderly population: the association between folic acid, B vitamins, vitamin D, coenzyme Q10 supplementation and cognitive ability. Nutrients, 15(5), 1243.

    • Ding, Z., Luo, L., Guo, S., Shen, Q., Zheng, Y., & Zhu, S. (2022). Non-linear association between folate/vitamin B12 status and cognitive function in older adults. Nutrients, 14(12), 2443.

    • Doets, E. L., Ueland, P. M., Tell, G. S., Vollset, S. E., Nygård, O. K., Van't Veer, P., ... & Eussen, S. J. (2014). Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: The Hordaland Health Study. British Journal of Nutrition, 111(6), 1085-1095.

    • Morris, M. S., Jacques, P. F., Rosenberg, I. H., & Selhub, J. (2007). Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. The American Journal of Clinical Nutrition, 85(1), 193-200.

    • Malouf, R., & Evans, J. G. (2008). Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database of Systematic Reviews, (4).

    • Moore, K., Porter, K., Doherty, L. C., Hughes, C. F., Ward, M., Hoey, L., ... & McNulty, H. (2018). A randomised controlled trial of B-vitamin supplementation on neuropsychiatric performance: Results from the BrainHOP trial. Proceedings of the Nutrition Society, 77, E73.

    • Tangney, C. C., Aggarwal, N. T., Li, H., Wilson, R. S., Decarli, C., Evans, D. A., & Morris, M. C. (2011). Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination. Neurology, 77(13), 1276-1282.

    • Corrada, M. M., Kawas, C. H., Hallfrisch, J., Muller, D., & Brookmeyer, R. (2005). Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer's & Dementia, 1(1), 11-18.

    • Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., & Mayeux, R. (2007). Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Archives of Neurology, 64(1), 86-92.

    • Smith, A. D., Smith, S. M., De Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., ... & Refsum, H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. Plos One, 5(9), e12244.

    • Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013). Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proceedings of the National Academy of Sciences, 110(23), 9523-9528.

    • Van der Zwaluw, N. L., Brouwer-Brolsma, E. M., Van de Rest, O., Van Wijngaarden, J. P., In’t Veld, P. H., Kourie, D. I., ... & De Groot, L. C. (2016). Folate and vitamin B12-related biomarkers in relation to brain volumes. Nutrients, 9(1), 8.

    • Rabensteiner, J., Hofer, E., Fauler, G., Fritz-Petrin, E., Benke, T., Dal-Bianco, P., ... & Herrmann, M. (2020). The impact of folate and vitamin B12 status on cognitive function and brain atrophy in healthy elderly and demented Austrians, a retrospective cohort study. Aging (Albany NY), 12(15), 15478.

    • Hooshmand, B., Mangialasche, F., Kalpouzos, G., Solomon, A., Kåreholt, I., Smith, A. D., ... & Kivipelto, M. (2016). Association of vitamin B12, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: A longitudinal population-based study. JAMA Psychiatry, 73(6), 606-613.

    • Djuricic, I., & Calder, P. C. (2021). Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021. Nutrients, 13(7), 2421.

    • Power, R., Prado-Cabrero, A., Mulcahy, R., Howard, A., & Nolan, J. M. (2019). The role of nutrition for the aging population: implications for cognition and Alzheimer's disease. Annual Review of Food Science and Technology, 10, 619-639.

    • Mao, X. Y., Yin, X. X., Guan, Q. W., Xia, Q. X., Yang, N., Zhou, H. H., ... & Jin, W. L. (2021). Dietary nutrition for neurological disease therapy: Current status and future directions. Pharmacology & Therapeutics, 226, 107861.

    • Wang, J., Han, L., Wang, D., Sun, Y., Huang, J., & Shahidi, F. (2021). Stability and stabilization of omega-3 oils: A review. Trends in Food Science & Technology, 118, 17-35.

    • Desai, A. K., Desai, A. K., Rush, J., Naveen, L., & Thaipisuttikul, P. (2011). Nutrition and nutritional supplements to promote brain health. Enhancing Cognitive Fitness in Adults: A Guide to the Use and Development of Community-Based Programs, 249-269.

    • Andriambelo, B., Stiffel, M., Roke, K., & Plourde, M. (2023). New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review. Ageing Research Reviews, 101835.

    • Shirai, N., & Suzuki, H. (2004). Effect of dietary docosahexaenoic acid and catechins on maze behavior in mice. Annals of Nutrition and Metabolism, 48(1), 51-58.

    • Wu, A., Ying, Z. H. E., & Gomez-Pinilla, F. (2007). Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. Journal of Neurotrauma, 24(10), 1587-1595.

    • Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., ... & Schneider, J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology, 60(7), 940-946.

    • Jernerén, F., Elshorbagy, A. K., Oulhaj, A., Smith, S. M., Refsum, H., & Smith, A. D. (2015). Brain atrophy in cognitively impaired elderly: The importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. The American Journal of Clinical Nutrition, 102(1), 215-221.

    • Zhang, Y., Chen, J., Qiu, J., Li, Y., Wang, J., & Jiao, J. (2016). Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. The American Journal of Clinical Nutrition, 103(2), 330-340.

    • Daiello, L. A., Gongvatana, A., Dunsiger, S., Cohen, R. A., Ott, B. R., & Alzheimer's Disease Neuroimaging Initiative. (2015). Association of fish oil supplement use with preservation of brain volume and cognitive function. Alzheimer's & Dementia, 11(2), 226-235.

    • Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., ... & Midas Investigators. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 6(6), 456-464.

    • Witte, A. V., Kerti, L., Hermannstädter, H. M., Fiebach, J. B., Schreiber, S. J., Schuchardt, J. P., ... & Flöel, A. (2014). Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cerebral Cortex, 24(11), 3059-3068.

    • Hashimoto, M., Yamashita, K., Kato, S., Tamai, T., Tanabe, Y., Mitarai, M., ... & Ohno, M. (2012). Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age-related cognitive decline in elderly Japanese with very mild dementia: A 2-year randomized, double-blind, placebo-controlled trial. J Aging Res Clin Pract, 1(3), 193-201.

    • Chew, E. Y., Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., Bernstein, P. S., & Age-Related Eye Disease Study 2 (AREDS2) Research Group. (2015). Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: The AREDS2 randomized clinical trial. Jama, 314(8), 791-801.

    • Külzow, N., Witte, A. V., Kerti, L., Grittner, U., Schuchardt, J. P., Hahn, A., & Floeel, A. (2016). Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. Journal of Alzheimer's Disease, 51(3), 713-725.

    • Eriksdotter, M., Vedin, I., Falahati, F., Freund-Levi, Y., Hjorth, E., Faxen-Irving, G., ... & Palmblad, J. (2015). Plasma fatty acid profiles in relation to cognition and gender in Alzheimer’s disease patients during oral omega-3 fatty acid supplementation: The omegad study. Journal of Alzheimer's Disease, 48(3), 805-812.

    • Lee, L. K., Shahar, S., Rajab, N., Yusoff, N. A. M., Jamal, R. A., & Then, S. M. (2013). The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study. The Journal of Nutritional Biochemistry, 24(5), 803-808.

    • Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., ... & Lu, Q. (2017). The n-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: A double-blind randomized controlled trial. Nutrients, 9(1), 54.

    • Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxen-Irving, G., Garlind, A., ... & Palmblad, J. (2006). ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Archives of Neurology, 63(10), 1402-1408.

    • Chiu, C. C., Su, K. P., Cheng, T. C., Liu, H. C., Chang, C. J., Dewey, M. E., ... & Huang, S. Y. (2008). The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(6), 1538-1544.

    • Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., ... & Aisen, P. S. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA, 304(17), 1903-1911.

    • Mahmoudi, M. J., Hedayat, M., Sharifi, F., Mirarefin, M., Nazari, N., Mehrdad, N., ... & Fakhrzadeh, H. (2014). Effect of low dose ω-3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study. Journal of Diabetes & Metabolic Disorders, 13, 1-11.

    • Phillips, M. A., Childs, C. E., Calder, P. C., & Rogers, P. J. (2015). No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer’s disease: A randomised controlled trial. International Journal of Molecular Sciences, 16(10), 24600-24613.

    • Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., ... & Olivier-Abbal, P. (2017). Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): A randomised, placebo-controlled trial. The Lancet Neurology, 16(5), 377-389.

    • Barbalho, S. M., Direito, R., Laurindo, L. F., Marton, L. T., Guiguer, E. L., Goulart, R. D. A., ... & Araújo, A. C. (2022). Ginkgo biloba in the aging process: A narrative review. Antioxidants, 11(3), 525.

    • Šamec, D., Karalija, E., Dahija, S., & Hassan, S. T. (2022). Biflavonoids: Important contributions to the health benefits of Ginkgo (Ginkgo biloba L.). Plants, 11(10), 1381.

    • Müller, W. E., Heiser, J., & Leuner, K. (2012). Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity. International Psychogeriatrics, 24(S1), S21-S24.

    • Yeh, K. Y., Shou, S. S., Lin, Y. X., Chen, C. C., Chiang, C. Y., & Yeh, C. Y. (2015). Effect of Ginkgo biloba extract on lipopolysaccharide‐induced anhedonic depressive‐like behavior in male rats. Phytotherapy Research, 29(2), 260-266.

    • Nada, S. E., & Shah, Z. A. (2012). Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2. Neurobiology of Disease, 46(1), 180-189.

    • Cho, K. S., Lee, I. M., Sim, S., Lee, E. J., Gonzales, E. L., Ryu, J. H., ... & Han, S. H. (2016). Ginkgo biloba extract (EGb 761®) inhibits glutamate‐induced up‐regulation of tissue plasminogen activator through inhibition of c‐fos translocation in rat primary cortical neurons. Phytotherapy Research, 30(1), 58-65.

    • Liu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., ... & Liu, Y. (2015). Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer’s disease. Brain, Behavior, and Immunity, 46, 121-131.

    • Zeng, K., Li, M., Hu, J., Mahaman, Y. A., Bao, J., Huang, F., ... & Wang, X. (2018). Ginkgo biloba extract EGb761 attenuates hyperhomocysteinemia-induced AD like tau hyperphosphorylation and cognitive impairment in rats. Current Alzheimer Research, 15(1), 89-99.

    • Wan, W., Zhang, C., Danielsen, M., Li, Q., Chen, W., Yuanjin, C. H. A. N., & Li, Y. (2016). EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse. Experimental Gerontology, 81, 92-100.

    • Allam, E. A., Assi, A. A., Badary, D. M., Farrag, M. M., & Nicola, M. A. (2024). Memantine versus Ginkgo biloba extract: A Comparative study on cognitive dysfunction treatment in a novel rat model. Planta Medica.

    • Oken, B. S., Storzbach, D. M., & Kaye, J. A. (1998). The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology, 55(11), 1409-1415.

    • Yuan, Q., Wang, C. W., Shi, J., & Lin, Z. X. (2017). Effects of Ginkgo biloba on dementia: An overview of systematic reviews. Journal of Ethnopharmacology, 195, 1-9.

    • Kandiah, N., Chan, Y. F., Chen, C., Dasig, D., Dominguez, J., Han, S. H., ... & Ihl, R. (2021). Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus. CNS Neuroscience & Therapeutics, 27(2), 149-162.

    • García-Alberca, J. M., Mendoza, S., & Gris, E. (2022). Benefits of treatment with ginkgo biloba extract EGb 761 alone or combined with acetylcholinesterase inhibitors in vascular dementia. Clinical Drug Investigation, 42(5), 391-402.

    • Hort, J., Duning, T., & Hoerr, R. (2023). Ginkgo biloba extract EGb 761 in the treatment of patients with mild neurocognitive impairment: A systematic review. Neuropsychiatric Disease and Treatment, 647-660.

    • Johnson, S. K., Diamond, B. J., Rausch, S., Kaufman, M., Shiflett, S. C., & Graves, L. (2006). The effect of Ginkgo biloba on functional measures in multiple sclerosis: A pilot randomized controlled trial. Explore, 2(1), 19-24.

    • Oskouei, D. S., Rikhtegar, R., Hashemilar, M., Sadeghi-Bazargani, H., Sharifi-Bonab, M., Sadeghi-Hokmabadi, E., ... & Sharifipour, E. (2013). The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: A double-blind, placebo-controlled, randomized clinical trial. Journal of Stroke and Cerebrovascular Diseases, 22(8), e557-e563.

    • Cui, M., You, T., Zhao, Y., Liu, R., Guan, Y., Liu, J., ... & Wang, X. (2023). Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial. Frontiers in Pharmacology, 14, 1147860.

    • Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Hörr, R. (1996). Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry, 29(02), 47-56.

    • Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., & Schatzberg, A. F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA, 278(16), 1327-1332.

    • Napryeyenko, O., & Borzenko, I. (2007). Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittelforschung, 57(01), 4-11.

    • Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., ... & Andrieu, S. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebo-controlled trial. The Lancet Neurology, 11(10), 851-859.

    • DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A., ... & Ginkgo Evaluation of Memory (GEM) Study Investigators. (2008). Ginkgo biloba for prevention of dementia: A randomized controlled trial. JAMA, 300(19), 2253-2262.

    • Yancheva, S., Ihl, R., Nikolova, G., Panayotov, P., Schlaefke, S., Hoerr, R., & Gindon Study Group. (2009). Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial. Aging and Mental Health, 13(2), 183-190.

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!